BlackRock Investment Management’s Crescent Biopharma, Inc. Common Stock CBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $232K | Hold |
381
| – | – | ﹤0.01% | 3191 |
|
|
2016
Q3 | $272K | Buy |
381
+16
| +4% | +$11.4K | ﹤0.01% | 3176 |
|
|
2016
Q2 | $265K | Buy |
365
+349
| +2,181% | +$253K | ﹤0.01% | 3229 |
|
|
2016
Q1 | $10K | Hold |
16
| – | – | ﹤0.01% | 3583 |
|
|
2015
Q4 | $9K | Hold |
16
| – | – | ﹤0.01% | 3696 |
|
|
2015
Q3 | $9K | Hold |
16
| – | – | ﹤0.01% | 3713 |
|
|
2015
Q2 | $13K | Buy |
16
+3
| +23% | +$2.44K | ﹤0.01% | 3590 |
|
|
2015
Q1 | $11K | Hold |
13
| – | – | ﹤0.01% | 3601 |
|
|
2014
Q4 | $10K | Hold |
13
| – | – | ﹤0.01% | 3667 |
|
|
2014
Q3 | $9K | Sell |
13
-1
| -7% | -$692 | ﹤0.01% | 3693 |
|
|
2014
Q2 | $12K | Sell |
14
-184
| -93% | -$158K | ﹤0.01% | 3557 |
|
|
2014
Q1 | $323K | Buy |
+198
| New | +$323K | ﹤0.01% | 3118 |
|